Treg cell-based therapies: challenges and perspectives
Raffin, Caroline, Vo, Linda T., Bluestone, Jeffrey A.
Published in Nature reviews. Immunology (01.03.2020)
Published in Nature reviews. Immunology (01.03.2020)
Get full text
Journal Article
CD28 Costimulation: From Mechanism to Therapy
Esensten, Jonathan H., Helou, Ynes A., Chopra, Gaurav, Weiss, Arthur, Bluestone, Jeffrey A.
Published in Immunity (Cambridge, Mass.) (17.05.2016)
Published in Immunity (Cambridge, Mass.) (17.05.2016)
Get full text
Journal Article
Immunotherapy: Building a bridge to a cure for type 1 diabetes
Bluestone, Jeffrey A, Buckner, Jane H, Herold, Kevan C
Published in Science (American Association for the Advancement of Science) (30.07.2021)
Published in Science (American Association for the Advancement of Science) (30.07.2021)
Get full text
Journal Article
Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting Cytokines
Kang, Jee Hye, Bluestone, Jeffrey A., Young, Arabella
Published in Trends in immunology (01.04.2021)
Published in Trends in immunology (01.04.2021)
Get full text
Journal Article
Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges
Sneddon, Julie B., Tang, Qizhi, Stock, Peter, Bluestone, Jeffrey A., Roy, Shuvo, Desai, Tejal, Hebrok, Matthias
Published in Cell stem cell (01.06.2018)
Published in Cell stem cell (01.06.2018)
Get full text
Journal Article
The Balancing Act between Cancer Immunity and Autoimmunity in Response to Immunotherapy
Young, Arabella, Quandt, Zoe, Bluestone, Jeffrey A
Published in Cancer immunology research (01.12.2018)
Published in Cancer immunology research (01.12.2018)
Get more information
Journal Article
Cell-based therapeutics: the next pillar of medicine
Fischbach, Michael A, Bluestone, Jeffrey A, Lim, Wendell A
Published in Science translational medicine (03.04.2013)
Published in Science translational medicine (03.04.2013)
Get more information
Journal Article
Peripherally induced tregs - role in immune homeostasis and autoimmunity
Yadav, Mahesh, Stephan, Stephen, Bluestone, Jeffrey A
Published in Frontiers in immunology (01.01.2013)
Published in Frontiers in immunology (01.01.2013)
Get full text
Journal Article
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
Schumann, Kathrin, Lin, Steven, Boyer, Eric, Simeonov, Dimitre R., Subramaniam, Meena, Gate, Rachel E., Haliburton, Genevieve E., Ye, Chun J., Bluestone, Jeffrey A., Doudna, Jennifer A., Marson, Alexander
Published in Proceedings of the National Academy of Sciences - PNAS (18.08.2015)
Published in Proceedings of the National Academy of Sciences - PNAS (18.08.2015)
Get full text
Journal Article
Regulatory T-cell therapy in transplantation: moving to the clinic
Tang, Qizhi, Bluestone, Jeffrey A
Published in Cold Spring Harbor perspectives in medicine (01.11.2013)
Published in Cold Spring Harbor perspectives in medicine (01.11.2013)
Get full text
Journal Article
Revisiting IL-2: Biology and therapeutic prospects
Abbas, Abul K, Trotta, Eleonora, R Simeonov, Dimitre, Marson, Alexander, Bluestone, Jeffrey A
Published in Science immunology (20.07.2018)
Published in Science immunology (20.07.2018)
Get more information
Journal Article
Self-antigen-Driven Activation Induces Instability of Regulatory T Cells during an Inflammatory Autoimmune Response
Bailey-Bucktrout, Samantha L., Martinez-Llordella, Marc, Zhou, Xuyu, Anthony, Bryan, Rosenthal, Wendy, Luche, Herve, Fehling, Hans J., Bluestone, Jeffrey A.
Published in Immunity (Cambridge, Mass.) (14.11.2013)
Published in Immunity (Cambridge, Mass.) (14.11.2013)
Get full text
Journal Article
Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency
Nguyen, David N, Roth, Theodore L, Li, P Jonathan, Chen, Peixin Amy, Apathy, Ryan, Mamedov, Murad R, Vo, Linda T, Tobin, Victoria R, Goodman, Daniel, Shifrut, Eric, Bluestone, Jeffrey A, Puck, Jennifer M, Szoka, Francis C, Marson, Alexander
Published in Nature biotechnology (01.01.2020)
Published in Nature biotechnology (01.01.2020)
Get full text
Journal Article
The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation
DuPage, Michel, Chopra, Gaurav, Quiros, Jason, Rosenthal, Wendy L, Morar, Malika M, Holohan, Dan, Zhang, Ruan, Turka, Laurence, Marson, Alexander, Bluestone, Jeffrey A
Published in Immunity (Cambridge, Mass.) (17.02.2015)
Published in Immunity (Cambridge, Mass.) (17.02.2015)
Get full text
Journal Article
Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation
Molofsky, Ari B., Van Gool, Frédéric, Liang, Hong-Erh, Van Dyken, Steven J., Nussbaum, Jesse C., Lee, Jinwoo, Bluestone, Jeffrey A., Locksley, Richard M.
Published in Immunity (Cambridge, Mass.) (21.07.2015)
Published in Immunity (Cambridge, Mass.) (21.07.2015)
Get full text
Journal Article
Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity
Wang, David, Quiros, Jason, Mahuron, Kelly, Pai, Chien-Chun, Ranzani, Valeria, Young, Arabella, Silveria, Stephanie, Harwin, Tory, Abnousian, Arbi, Pagani, Massimiliano, Rosenblum, Michael D., Van Gool, Frederic, Fong, Lawrence, Bluestone, Jeffrey A., DuPage, Michel
Published in Cell reports (Cambridge) (12.06.2018)
Published in Cell reports (Cambridge) (12.06.2018)
Get full text
Journal Article